VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMW 2021 | Improving global accessibility of myeloma treatment

Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, talks on improving the accessibility of treatment for patients with myeloma worldwide, highlighting the global efforts from organizations such as the International Myeloma Society to make treatments like chimeric antigen receptor (CAR) T-cell therapy available globally. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.


Noopur Raje, MD, has participated in consulting for Amgen, BMS, GSK, Janssen, Takeda, Oncopeptides, Karyopharm, Bluebird Bio, Pfizer, AstraZeneca; has participated in the advisory boards of Immuneel and Caribou; and has received research funding from Bluebird Bio,

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter